Development and Assessment of a Model for Predicting Individualized Outcomes in Patients With Oropharyngeal Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Development and Assessment of a Model for Predicting Individualized Outcomes in Patients With Oropharyngeal Cancer

Published:2021-08-09 Issue:8 Volume:4 Page:e2120055
ISSN:2574-3805
Container-title:JAMA Network Open
language:en
Short-container-title:JAMA Netw Open

Author:

Beesley Lauren J.¹,Shuman Andrew G.²,Mierzwa Michelle L.³,Bellile Emily L.¹,Rosen Benjamin S.³,Casper Keith A.²,Ibrahim Mohannad⁴,Dermody Sarah M.²,Wolf Gregory T.²,Chinn Steven B.²,Spector Matthew E.²,Baatenburg de Jong Robert J.⁵,Dronkers Emilie A. C.⁵,Taylor Jeremy M. G.¹

Affiliation:

1. Department of Biostatistics, University of Michigan, Ann Arbor

2. Department of Otolaryngology–Head and Neck Surgery, University of Michigan, Ann Arbor

3. Department of Radiation Oncology, University of Michigan, Ann Arbor

4. Department of Radiology, University of Michigan, Ann Arbor

5. Department of Otorhinolaryngology–Head and Neck Surgery, Erasmus Cancer Institute, Erasmus University Medical Center, Rotterdam, the Netherlands

Publisher

American Medical Association (AMA)

Subject

General Medicine

Link

https://jamanetwork.com/journals/jamanetworkopen/articlepdf/2782832/beesley_2021_oi_210592_1627686267.13168.pdf

Reference46 articles.

1. Deintensification candidate subgroups in human papillomavirus–related oropharyngeal cancer according to minimal risk of distant metastasis.;O’Sullivan;J Clin Oncol,2013

2. Mature results of a prospective study of deintensified chemoradiotherapy for low-risk human papillomavirus–associated oropharyngeal squamous cell carcinoma.;Chera;Cancer,2018

3. Development and validation of a staging system for HPV-related oropharyngeal cancer by the International Collaboration on Oropharyngeal Cancer Network for Staging (ICON-S): a multicentre cohort study.;O’Sullivan;Lancet Oncol,2016

4. E1308: Phase II trial of induction chemotherapy followed by reduced-dose radiation and weekly cetuximab in patients with HPV-associated resectable squamous cell carcinoma of the oropharynx: ECOG-ACRIN Cancer Research Group.;Marur;J Clin Oncol,2017

5. De-escalation treatment protocols for human papillomavirus–associated oropharyngeal squamous cell carcinoma: a systematic review and meta-analysis of current clinical trials.;Masterson;Eur J Cancer,2014

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sex and Marital-Status Differences in Delayed Initiation for Pharyngeal Cancer Treatment, Before and After Medicaid Expansion;2024-05-31

2. Calibration plots for multistate risk prediction models;Statistics in Medicine;2024-05-08

3. Population-Based Prognostic Models for Head and Neck Cancers Using National Cancer Registry Data from Taiwan;Journal of Epidemiology and Global Health;2024-02-14

4. Outcome prediction models incorporating clinical variables for Head and Neck Squamous cell Carcinoma: A systematic review of methodological conduct and risk of bias;Radiotherapy and Oncology;2023-06

5. Examining the effect of Medicaid expansion on early detection of head and neck cancer of the oral cavity and pharynx by HPV‐type and generosity of dental benefits;Cancer Reports;2023-05-29

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3